Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5578
Gene Symbol: PRKCA
PRKCA 		0.090 AlteredExpression group BEFREE β-catenin, p-PKCα, and p-CREB were upregulated in both SP cells and breast tumors. 21665913 2011
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2 		0.500 Biomarker group BEFREE β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression. 23720052 2013
Entrez Id: 3476
Gene Symbol: IGBP1
IGBP1 		0.300 Biomarker group CTD_human α4 is highly expressed in carcinogen-transformed human cells and primary human cancers. 21339737 2011
Entrez Id: 2817
Gene Symbol: GPC1
GPC1 		0.010 Biomarker group BEFREE α3 Chains of type V collagen regulate breast tumour growth via glypican-1. 28102194 2017
Entrez Id: 2099
Gene Symbol: ESR1
ESR1 		0.500 GeneticVariation group LHGDN [The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer]. 15842934 2005
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1 		0.500 CausalMutation group CLINVAR [The measuring for depth of papillary excavation by microcomputer (author's transl)]. 7257965 1980
Entrez Id: 7424
Gene Symbol: VEGFC
VEGFC 		0.400 Biomarker group CTD_human [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer]. 18509974 2008
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2 		0.400 Biomarker group CTD_human [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer]. 18509974 2008
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1 		0.500 Biomarker group CTD_human [The correlation between chemotherapeutic efficacy and breast cancer susceptibility gene 1 and class IIIβ-tubulin protein expression in non-small cell lung cancer patients]. 21781528 2011
Entrez Id: 10381
Gene Symbol: TUBB3
TUBB3 		0.310 Biomarker group CTD_human [The correlation between chemotherapeutic efficacy and breast cancer susceptibility gene 1 and class IIIβ-tubulin protein expression in non-small cell lung cancer patients]. 21781528 2011
Entrez Id: 1543
Gene Symbol: CYP1A1
CYP1A1 		0.400 Biomarker group CTD_human [Study on serum organochlorines pesticides (DDTs) level, CYP1A1 genetic polymorphism and risk of breast cancer: a case control study]. 16792888 2006
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1 		0.500 CausalMutation group CLINVAR [Simple and rapid technic of grouping of streptococci]. 824983 1976
Entrez Id: 1806
Gene Symbol: DPYD
DPYD 		0.340 Biomarker group LHGDN [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer]. 18347391 2008
Entrez Id: 5744
Gene Symbol: PTHLH
PTHLH 		0.400 Biomarker group LHGDN [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients]. 17213971 2006
Entrez Id: 3381
Gene Symbol: IBSP
IBSP 		0.330 Biomarker group LHGDN [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients]. 17213971 2006
Entrez Id: 30811
Gene Symbol: HUNK
HUNK 		0.010 Biomarker group LHGDN [Proteinkinase MAK-V/Hunk as a possible dianostic and prognostic marker of human breast carcinoma]. 15575376 2005
Entrez Id: 7124
Gene Symbol: TNF
TNF 		0.400 GeneticVariation group LHGDN [Polymorphisms of tumor necrosis factor genes in sporadic and hereditary breast cancer]. 18416134 2007
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1 		0.500 GeneticVariation group LHGDN [Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg]. 17990525 2007
Entrez Id: 9077
Gene Symbol: DIRAS3
DIRAS3 		0.050 AlteredExpression group LHGDN [NOEY2 gene mRNA expression in breast cancer tissue and its relation to clinicopathological parameters]. 12485503 2002
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1 		0.500 GeneticVariation group LHGDN [Molecular alterations in breast cancer: clinical implications and new analytical tools]. 15936476 2005
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2 		0.500 GeneticVariation group LHGDN [Molecular alterations in breast cancer: clinical implications and new analytical tools]. 15936476 2005
Entrez Id: 2272
Gene Symbol: FHIT
FHIT 		0.100 AlteredExpression group LHGDN [Loss of fragile histidine triad expression and metastasis in breast cancer]. 12452072 2002
Entrez Id: 3620
Gene Symbol: IDO1
IDO1 		0.320 Biomarker group LHGDN [Indoleamine 2,3-dioxygenase expression in breast cancer patients during chemotherapy]. 19106591 2008
Entrez Id: 6850
Gene Symbol: SYK
SYK 		0.060 AlteredExpression group LHGDN [Expression of tyrosine kinase Syk in breast cancer and their clinical significance]. 15062056 2004
Entrez Id: 4318
Gene Symbol: MMP9
MMP9 		0.400 Biomarker group LHGDN [Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis]. 12753719 2003